14.65
-0.14
(-0.95%)
At close: January 14 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
867,547.00
785,368.00
718,590.00
668,494.00
664,233.00
Operating Expense
770,379.00
723,121.00
668,561.00
608,428.00
636,584.00
Operating Income
97,168.00
62,247.00
50,029.00
60,066.00
27,649.00
Net Non Operating Interest Income Expense
-40,411.00
-41,720.00
-34,475.00
-31,383.00
-36,457.00
Other Income Expense
-14,270.00
-10,523.00
-4,373.00
-650.00
-25,629.00
Pretax Income
42,487.00
10,004.00
11,181.00
28,033.00
-34,437.00
Tax Provision
11,512.00
2,966.00
513.00
7,385.00
-9,950.00
Net Income Common Stockholders
30,975.00
7,038.00
10,668.00
20,648.00
-24,487.00
Diluted NI Available to Com Stockholders
30,975.00
7,038.00
10,668.00
20,648.00
-24,487.00
Basic EPS
0.42
0.10
0.15
0.31
-0.37
Diluted EPS
0.42
0.10
0.15
0.31
-0.37
Basic Average Shares
73,870.76
72,955.98
71,589.10
67,039.12
67,014.61
Diluted Average Shares
73,870.76
72,955.98
71,589.10
67,039.12
67,014.61
Total Expenses
770,379.00
723,121.00
668,561.00
608,428.00
636,584.00
Net Income from Continuing & Discontinued Operation
30,975.00
7,038.00
10,668.00
20,648.00
-24,487.00
Normalized Income
34,273.94
7,892.07
4,082.67
21,104.67
-6,664.83
Interest Income
2,373.00
2,242.00
1,838.00
1,725.00
2,949.00
Interest Expense
38,805.00
40,642.00
33,842.00
30,438.00
34,029.00
Net Interest Income
-40,411.00
-41,720.00
-34,475.00
-31,383.00
-36,457.00
EBIT
81,292.00
50,646.00
45,023.00
58,471.00
-408.00
EBITDA
131,608.00
100,269.00
92,360.00
111,540.00
77,251.00
Reconciled Depreciation
50,316.00
49,623.00
47,337.00
53,069.00
77,659.00
Net Income from Continuing Operation Net Minority Interest
30,975.00
7,038.00
10,668.00
20,648.00
-24,487.00
Total Unusual Items Excluding Goodwill
-4,525.00
-1,214.00
6,902.00
-620.00
-25,064.00
Total Unusual Items
-4,525.00
-1,214.00
6,902.00
-620.00
-25,064.00
Normalized EBITDA
136,133.00
101,483.00
85,458.00
112,160.00
102,315.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,226.06
-359.93
316.67
-163.33
-7,241.83
12/31/2020 - 4/20/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EXE.TO Extendicare Inc.
10.31
+1.88%
WELL.TO WELL Health Technologies Corp.
6.68
+0.91%
DR.TO Medical Facilities Corporation
15.63
+0.90%
AIDX.TO Healwell AI Inc.
1.7400
+2.96%
DNTL.TO dentalcorp Holdings Ltd.
7.87
-0.38%
FMS Fresenius Medical Care AG
22.64
+1.34%
EXETF Extendicare Inc.
7.16
0.00%
CRRX.TO CareRx Corporation
2.1700
-0.91%
CMPS COMPASS Pathways plc
3.3600
-0.30%
ENSG The Ensign Group, Inc.
133.50
+0.88%